TG Therapeutics cancer trial setback sends shares tumblingTG Therapeutics (TG) has suffered a setback in its blood cancer drug trial, as the data available was Share XTG Therapeutics cancer trial setback sends shares tumblinghttps://pharmaphorum.com/news/tg-therapeutics-cancer-trial-setback-sends-shares-tumbling/
